Management of NSCLC Disease Progression After First-Line...

Drugs 2016 / 5 Vol. 76; Iss. 8

Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?

Califano, Raffaele, Romanidou, Ourania, Mountzios, Giannis, Landi, Lorenza, Cappuzzo, Federico, Blackhall, Fiona
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
76
Language:
english
Journal:
Drugs
DOI:
10.1007/s40265-016-0578-z
Date:
May, 2016
File:
PDF, 478 KB
english, 2016
Conversion to is in progress
Conversion to is failed